145 related articles for article (PubMed ID: 12447698)
1. Induction of RECK by nonsteroidal anti-inflammatory drugs in lung cancer cells.
Liu LT; Chang HC; Chiang LC; Hung WC
Oncogene; 2002 Nov; 21(54):8347-50. PubMed ID: 12447698
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion.
Liu LT; Chang HC; Chiang LC; Hung WC
Cancer Res; 2003 Jun; 63(12):3069-72. PubMed ID: 12810630
[TBL] [Abstract][Full Text] [Related]
3. [Nonsteroidal anti-inflammatory drug NS398 regulates the RECK gene expression in the prostate carcinoma strain DU145].
Xu ZY; Gao JP; Sun YH; Zhang ZY; Ge JP; Xu CL; Wang LH
Zhonghua Nan Ke Xue; 2008 Apr; 14(4):303-6. PubMed ID: 18481419
[TBL] [Abstract][Full Text] [Related]
4. The nonsteroidal anti-inflammatory drug NS398 reactivates SPARC expression via promoter demethylation to attenuate invasiveness of lung cancer cells.
Pan MR; Chang HC; Chuang LY; Hung WC
Exp Biol Med (Maywood); 2008 Apr; 233(4):456-62. PubMed ID: 18367635
[TBL] [Abstract][Full Text] [Related]
5. Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung.
Takemoto N; Tada M; Hida Y; Asano T; Cheng S; Kuramae T; Hamada J; Miyamoto M; Kondo S; Moriuchi T
Lung Cancer; 2007 Dec; 58(3):376-83. PubMed ID: 17714826
[TBL] [Abstract][Full Text] [Related]
6. RECK negatively regulates matrix metalloproteinase-9 transcription.
Takagi S; Simizu S; Osada H
Cancer Res; 2009 Feb; 69(4):1502-8. PubMed ID: 19208844
[TBL] [Abstract][Full Text] [Related]
7. Enhanced 5-fluorouracil cytotoxicity in high cyclooxygenase-2 expressing colorectal cancer cells and xenografts induced by non-steroidal anti-inflammatory drugs via downregulation of dihydropyrimidine dehydrogenase.
Réti A; Pap E; Adleff V; Jeney A; Kralovánszky J; Budai B
Cancer Chemother Pharmacol; 2010 Jul; 66(2):219-27. PubMed ID: 19830428
[TBL] [Abstract][Full Text] [Related]
8. 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is up-regulated by flurbiprofen and other non-steroidal anti-inflammatory drugs in human colon cancer HT29 cells.
Chi X; Freeman BM; Tong M; Zhao Y; Tai HH
Arch Biochem Biophys; 2009 Jul; 487(2):139-45. PubMed ID: 19501039
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human telomerase reverse transcriptase by nonsteroidal antiinflammatory drugs in colon carcinoma.
He H; Xia HH; Wang JD; Gu Q; Lin MC; Zou B; Lam SK; Chan AO; Yuen MF; Kung HF; Wong BC
Cancer; 2006 Mar; 106(6):1243-9. PubMed ID: 16444744
[TBL] [Abstract][Full Text] [Related]
10. Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation.
Chang HC; Cho CY; Hung WC
Cancer Res; 2006 Sep; 66(17):8413-20. PubMed ID: 16951151
[TBL] [Abstract][Full Text] [Related]
11. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.
Takeuchi T; Hisanaga M; Nagao M; Ikeda N; Fujii H; Koyama F; Mukogawa T; Matsumoto H; Kondo S; Takahashi C; Noda M; Nakajima Y
Clin Cancer Res; 2004 Aug; 10(16):5572-9. PubMed ID: 15328199
[TBL] [Abstract][Full Text] [Related]
12. RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness.
Kang HG; Kim HS; Kim KJ; Oh JH; Lee MR; Seol SM; Han I
J Orthop Res; 2007 May; 25(5):696-702. PubMed ID: 17262820
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal anti-inflammatory drugs suppress glioma via 15-hydroxyprostaglandin dehydrogenase.
Wakimoto N; Wolf I; Yin D; O'Kelly J; Akagi T; Abramovitz L; Black KL; Tai HH; Koeffler HP
Cancer Res; 2008 Sep; 68(17):6978-86. PubMed ID: 18757412
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells.
Cho CY; Wang JH; Chang HC; Chang CK; Hung WC
J Cell Physiol; 2007 Oct; 213(1):65-9. PubMed ID: 17443689
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma.
Span PN; Sweep CG; Manders P; Beex LV; Leppert D; Lindberg RL
Cancer; 2003 Jun; 97(11):2710-5. PubMed ID: 12767082
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.
Chen JJ; Yao PL; Yuan A; Hong TM; Shun CT; Kuo ML; Lee YC; Yang PC
Clin Cancer Res; 2003 Feb; 9(2):729-37. PubMed ID: 12576442
[TBL] [Abstract][Full Text] [Related]
17. Influence of persistent canine distemper virus infection on expression of RECK, matrix-metalloproteinases and their inhibitors in a canine macrophage/monocytic tumour cell line (DH82).
Puff C; Krudewig C; Imbschweiler I; Baumgärtner W; Alldinger S
Vet J; 2009 Oct; 182(1):100-7. PubMed ID: 18684651
[TBL] [Abstract][Full Text] [Related]
18. [Expression and significance of the matrix metalloproteinase inhibitor RECK gene in prostate cell strains].
Xu ZY; Gao JP; Zhang ZP; Ge JP; Xu CL; Sun YH
Zhonghua Nan Ke Xue; 2005 Oct; 11(10):727-30. PubMed ID: 16281502
[TBL] [Abstract][Full Text] [Related]
19. Expression of membrane-anchored matrix metalloproteinase inhibitor reversion inducing cysteine rich protein with Kazal motifs in murine cell lines.
Takagi S; Hoshino Y; Osaki T; Okumura M; Fuginaga T
Exp Oncol; 2007 Mar; 29(1):30-4. PubMed ID: 17431385
[TBL] [Abstract][Full Text] [Related]
20. RECK is a target of Epstein-Barr virus latent membrane protein 1.
Liu LT; Peng JP; Chang HC; Hung WC
Oncogene; 2003 Nov; 22(51):8263-70. PubMed ID: 14614450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
